EU could approve GE/Instrumentarium deal by April:
This article was originally published in Clinica
The European Commission has until April 3 to decide whether to allow General Electric Medical Systems' proposed E2bn ($2.2bn) acquisition of Finnish medical technology firm Instrumentarium to go ahead unimpeded. It could alternatively decide to launch a four-month investigation such as the one being conducted into Siemens' deal with Draegerwerk. GE notified the Commission of its merger plan on February 28.
You may also be interested in...
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.
Pfizer's third US FDA warning letter since 2018 goes to injectables site in Vizag, India; tells the company to up its game in sterility testing and in the microbiology lab.
Gilead lands on Second Genome as its first partner to apply microbiome analysis to pipeline assets to look for biomarkers. Companies also team up on GI drug discovery.